Dermatology - BroadcastMed

ADVERTISEMENT

News

Are New Therapies on the Horizon for Painful Skin Condition?

Are New Therapies on the Horizon for Painful Skin Condition?

Fast Facts on Precision Medicine: Personalizing Care for Scleroderma, an Autoimmune Disease

Fast Facts on Precision Medicine: Personalizing Care for Scleroderma, an Autoimmune Disease

Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin Biology

Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin Biology

New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results

New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results

Collateral Damage: CAR T, COVID and the Cytokine Storm - Advances at Penn Medicine and the Abramson Cancer Center

Collateral Damage: CAR T, COVID and the Cytokine Storm - Advances at Penn Medicine and the Abramson Cancer Center

Simple Skin Test Can Confirm Parkinson's Diagnosis

Simple Skin Test Can Confirm Parkinson's Diagnosis

Roswell Park Experts Share Insights on Diagnosis and Treatment of Head/Neck Cancers at AHNS 2021

Roswell Park Experts Share Insights on Diagnosis and Treatment of Head/Neck Cancers at AHNS 2021

Immunotherapy Combination Shows Benefit for Patients with Advanced Melanoma, Phase 3 Trial Shows

Immunotherapy Combination Shows Benefit for Patients with Advanced Melanoma, Phase 3 Trial Shows

In Landmark Study, an Arthritis Drug Appears to Prevent Deadly Acute Graft-versus-host Disease after Bone Marrow Transplant

In Landmark Study, an Arthritis Drug Appears to Prevent Deadly Acute Graft-versus-host Disease after Bone Marrow Transplant

First FDA Approval of CAR T-Cell Therapy for Multiple Myeloma Marks Milestone for Patients

First FDA Approval of CAR T-Cell Therapy for Multiple Myeloma Marks Milestone for Patients

Dana-Farber to Offer First CAR T-Cell Therapy for Indolent Follicular Lymphoma Following FDA Approval

Dana-Farber to Offer First CAR T-Cell Therapy for Indolent Follicular Lymphoma Following FDA Approval

Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer

Immunotherapy Combination Improves Outcomes in Advanced Kidney Cancer

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

Using CBL0137 To Treat Patients With Advanced Extremity Melanoma or Sarcoma

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

CAR T-Cell Therapy Generates Lasting Remissions in Patients with Multiple Myeloma

CAR T-Cell Therapy Generates Lasting Remissions in Patients with Multiple Myeloma

Targeted Therapy for Children with Leukemia Can Provide Substantial Benefit, Study Finds

Targeted Therapy for Children with Leukemia Can Provide Substantial Benefit, Study Finds

Response and Prognosis with Neoadjuvant Therapy in Melanoma

Response and Prognosis with Neoadjuvant Therapy in Melanoma

Personalized Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma, Study Shows

Personalized Vaccine Produces Long-Lasting Anti-Tumor Response in Patients with Melanoma, Study Shows

New Procedure Provides Relief for Thousands of Prostate Cancer Patients Treated with Radiation Therapy

New Procedure Provides Relief for Thousands of Prostate Cancer Patients Treated with Radiation Therapy

$CAR T-Cell Therapy Now Available at Fox Chase for Relapsed and Refractory Mantle Cell Lymphoma$ News

CAR T-Cell Therapy Now Available at Fox Chase for Relapsed and Refractory Mantle Cell Lymphoma

Showing 1 - 20 of 49 results

Previous| 1 | 2 | 3 |Next

ADVERTISEMENT

ADVERTISEMENT